BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1588459)

  • 21. Automated method for determining Instron Residual Seal Force of glass vial/rubber closure systems.
    Ludwig JD; Nolan PD; Davis CW
    J Parenter Sci Technol; 1993; 47(5):211-53. PubMed ID: 8263661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum in erythropoietin formulations: lyophilized versus liquid forms.
    Veiga M; Bohrer D; Noremberg S; Mattiazzi P; do Nascimento PC; de Carvalho LM
    Ren Fail; 2013; 35(3):391-5. PubMed ID: 23343454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a parenteral formulation of trimelamol, a synthetic S-triazine carbinolamine-containing cytotoxic agent.
    Gibson M; Denham AJ; Taylor PM; Payne NI
    J Parenter Sci Technol; 1990; 44(6):306-13. PubMed ID: 2277318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing the lyophilization cycle and the consequences of collapse on the pharmaceutical acceptability of Erwinia L-asparaginase.
    Adams GD; Ramsay JR
    J Pharm Sci; 1996 Dec; 85(12):1301-5. PubMed ID: 8961143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different rubber stoppers; the effect of sterilization on the number of particles released.
    Mannermaa JP; Muttonen E; Yliruusi J; Juppo A
    J Parenter Sci Technol; 1992; 46(3):73-7. PubMed ID: 1522444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures.
    Nassar MN; Nesarikar VV; Lozano R; Huang Y; Palaniswamy V
    Pharm Dev Technol; 2005; 10(2):227-32. PubMed ID: 15926671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of the closure format on the storage stability and moisture content of freeze-dried influenza antigen.
    Duralliu A; Matejtschuk P; Dubey S; Koroma H; Gubinelli F; Williams DR
    Vaccine; 2019 Jul; 37(32):4485-4490. PubMed ID: 31277955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.
    Kuu WY; Hardwick LM; Akers MJ
    Int J Pharm; 2006 Apr; 313(1-2):99-113. PubMed ID: 16513303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical fundamentals of glass, rubber, and plastic sterile packaging systems.
    Sacha GA; Saffell-Clemmer W; Abram K; Akers MJ
    Pharm Dev Technol; 2010; 15(1):6-34. PubMed ID: 20088708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gas-solid chromatographic determination of moisture in lyophilized pharmaceutical products.
    Lyman GW; Johnson RN
    J Assoc Off Anal Chem; 1979 Jan; 62(1):71-4. PubMed ID: 422507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicity potential of compounds found in parenteral solutions with rubber stoppers.
    Danielson JW
    J Parenter Sci Technol; 1992; 46(2):43-7. PubMed ID: 1588456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of chinosol absorption by rubber stoppers used to seal glass vials containing tuberculin PPD Mantoux solutions.
    Landi S; Held HR
    Bull World Health Organ; 1965; 33(3):395-404. PubMed ID: 5294923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freeze drying formulation using microscale and design of experiment approaches: a case study using granulocyte colony-stimulating factor.
    Grant Y; Matejtschuk P; Bird C; Wadhwa M; Dalby PA
    Biotechnol Lett; 2012 Apr; 34(4):641-8. PubMed ID: 22187075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of rubber closures with powders for parenteral administration.
    Jaehnke RW; Kreuter J; Ross G
    J Parenter Sci Technol; 1990; 44(5):282-8. PubMed ID: 2250205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubber closures as a source of haze in freeze dried parenterals: test methodology for closure evaluation.
    Pikal MJ; Lang JE
    J Parenter Drug Assoc; 1978; 32(4):162-73. PubMed ID: 249783
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein purification process engineering. Freeze drying: A practical overview.
    Gatlin LA; Nail SL
    Bioprocess Technol; 1994; 18():317-67. PubMed ID: 7764173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biohazards in pharmaceutical freeze drying.
    Hermanský M; Graichman T
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1990; 33(2):83-8. PubMed ID: 2098908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Product on Stopper" in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern?
    Mehta SB; Roy S; Yang HC
    J Pharm Sci; 2018 Jun; 107(6):1736-1740. PubMed ID: 29432763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of final container residual moisture in freeze-dried biological products.
    May JC; Wheeler RM; Etz N; Del Grosso A
    Dev Biol Stand; 1992; 74():153-64. PubMed ID: 1592165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbial barrier assessment of Tyvek stopper packaging for rubber closures.
    Moldenhauer JE; Bass SA; Kupinski MJ; Walters ML; Rubio SL
    PDA J Pharm Sci Technol; 1996; 50(6):391-8. PubMed ID: 9038086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.